Bioengineering

Scientists have created a non-invasive technology for measuring glucose levels in blood.

New method makes room for DNA insertions

RSOM-Aufnahmen von Haut eines gesunden Probanden (links), eines Patienten mit Diabetes (mitte) und eines Patienten mit Diabetes und Neuropathie (rechts).

Changes in small blood vessels are a common consequence of diabetes development. Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have now developed a method that can be used to measure these microvascular changes in the…

Sporadic Parkinson's Disease (sPD) is a progressive neurodegenerative disorder influenced by both genetic and environmental factors. While mitochondrial dysfunction contributes to this condition, its role across disease progression remains unclear.…

Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise…

Alzheimer's, stroke, multiple sclerosis and other neurological diseases cause severe damage due to neuroinflammation mediated by immune cells. Managing this inflammation poses a significant medical challenge because the brain is protected by the…

Bioengineering

News

Non-invasive Glucose Sensing in Blood

Expanding the gene editing toolbox

Examining Diabetes with a Skin Scanner and AI

Breakthrough Discovery Unravels Metabolic Mysteries in Sporadic Parkinson’s Disease Etiology

DeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Time

A New Ally in Fighting Brain Diseases: Our Very Own Skull